20-years follow-up of ASCOT-legacy - report from ESH-ISH2021

Prof. Peter Sever speaks about the ASCOT study, what was and is the most influential cardiovascular prevention trial in the last two decades. It is the basis of many hypertension guidelines. He speaks about the past of ASCOT, the recent data and what does it tell us for the future. Video: https://congressreport.eu/scientific-contents/interview:long-term-benefits-blood-pressure-treatment-incidence-atrial-fibrillation-heart-failure-and-cardiovascular-morbidity-and-mortality-20-years-follow-ascot-legacy